Intervention Review

Angiotensin receptor blockers for heart failure

  1. Balraj S Heran1,*,
  2. Vijaya M Musini1,
  3. Ken Bassett1,
  4. Rod S Taylor2,
  5. James M Wright1

Editorial Group: Cochrane Heart Group

Published Online: 18 APR 2012

Assessed as up-to-date: 14 DEC 2010

DOI: 10.1002/14651858.CD003040.pub2

How to Cite

Heran BS, Musini VM, Bassett K, Taylor RS, Wright JM. Angiotensin receptor blockers for heart failure. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD003040. DOI: 10.1002/14651858.CD003040.pub2.

Author Information

  1. 1

    University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, British Columbia, Canada

  2. 2

    Peninsula College of Medicine and Dentistry, Universities of Exeter & Plymouth, Exeter, UK

*Balraj S Heran, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver, British Columbia, V6T 1Z3, Canada. bsheran@ti.ubc.ca. bsheran@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 18 APR 2012

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    P. Pabón Osuna, J. Martín Moreiras, I. Cruz González, C. Martín Luengo, Tratamiento de la insuficiencia cardiaca crónica, Medicine - Programa de Formación Médica Continuada Acreditado, 2013, 11, 35, 2146

    CrossRef

  2. 2
    Sera Tort, How do angiotensin receptor blockers (ARBs) affect outcomes in people with heart failure?, Cochrane Clinical Answers,